Refractory Melasma

1

Review clinical trials related to Refractory Melasma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Fractional Erbium YAG Laser vs Intradermal and Systemic Tranexamic Acid

Melasma is a common acquired disorder of hyperpigmentaion caused by increased melanin production by melanocytes. Melasma is a name derived from the Greek word melas meaning black.It is characterized by the appearance of brownish or grayish symmetrical patches on sun-exposed skin, most commonly on the face. Compared to men, women are more likely to be affected.

Participants needed: 45
Trial details
Age: 18-40Biological sex: AllType: InterventionalSponsor: EgymedicalpediaUpdated: Jul 26, 2024Locations: 1
Eligibility criteria

Pregnancy [+3]